426 related articles for article (PubMed ID: 23878224)
1. Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer.
Bosurgi L; Bernink JH; Delgado Cuevas V; Gagliani N; Joannas L; Schmid ET; Booth CJ; Ghosh S; Rothlin CV
Proc Natl Acad Sci U S A; 2013 Aug; 110(32):13091-6. PubMed ID: 23878224
[TBL] [Abstract][Full Text] [Related]
2. Diversification of TAM receptor tyrosine kinase function.
Zagórska A; Través PG; Lew ED; Dransfield I; Lemke G
Nat Immunol; 2014 Oct; 15(10):920-8. PubMed ID: 25194421
[TBL] [Abstract][Full Text] [Related]
3. TAM receptors and the regulation of erythropoiesis in mice.
Tang H; Chen S; Wang H; Wu H; Lu Q; Han D
Haematologica; 2009 Mar; 94(3):326-34. PubMed ID: 19211638
[TBL] [Abstract][Full Text] [Related]
4. Axl and Mertk Receptors Cooperate to Promote Breast Cancer Progression by Combined Oncogenic Signaling and Evasion of Host Antitumor Immunity.
Davra V; Kumar S; Geng K; Calianese D; Mehta D; Gadiyar V; Kasikara C; Lahey KC; Chang YJ; Wichroski M; Gao C; De Lorenzo MS; Kotenko SV; Bergsbaken T; Mishra PK; Gause WC; Quigley M; Spires TE; Birge RB
Cancer Res; 2021 Feb; 81(3):698-712. PubMed ID: 33239426
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of hepatic physiology and injury by the TAM receptors Axl and Mer.
Zagórska A; Través PG; Jiménez-García L; Strickland JD; Oh J; Tapia FJ; Mayoral R; Burrola P; Copple BL; Lemke G
Life Sci Alliance; 2020 Aug; 3(8):. PubMed ID: 32571802
[TBL] [Abstract][Full Text] [Related]
6. Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor.
Yokoyama Y; Lew ED; Seelige R; Tindall EA; Walsh C; Fagan PC; Lee JY; Nevarez R; Oh J; Tucker KD; Chen M; Diliberto A; Vaaler H; Smith KM; Albert A; Li G; Bui JD
Cancer Res; 2019 Apr; 79(8):1996-2008. PubMed ID: 30723115
[TBL] [Abstract][Full Text] [Related]
7. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells.
Seitz HM; Camenisch TD; Lemke G; Earp HS; Matsushima GK
J Immunol; 2007 May; 178(9):5635-42. PubMed ID: 17442946
[TBL] [Abstract][Full Text] [Related]
8. The TAM receptor tyrosine kinases Axl and Mer drive the maintenance of highly phagocytic macrophages.
Jiménez-García L; Mayer C; Burrola PG; Huang Y; Shokhirev MN; Lemke G
Front Immunol; 2022; 13():960401. PubMed ID: 35967387
[TBL] [Abstract][Full Text] [Related]
9. Retinal self-antigen induces a predominantly Th1 effector response in Axl and Mertk double-knockout mice.
Ye F; Han L; Lu Q; Dong W; Chen Z; Shao H; Kaplan HJ; Li Q; Lu Q
J Immunol; 2011 Oct; 187(8):4178-86. PubMed ID: 21918185
[TBL] [Abstract][Full Text] [Related]
10. TAM receptors are dispensable in the phagocytosis and killing of bacteria.
Williams JC; Craven RR; Earp HS; Kawula TH; Matsushima GK
Cell Immunol; 2009; 259(2):128-34. PubMed ID: 19625016
[TBL] [Abstract][Full Text] [Related]
11. Loss of the receptor tyrosine kinase Axl leads to enhanced inflammation in the CNS and delayed removal of myelin debris during experimental autoimmune encephalomyelitis.
Weinger JG; Brosnan CF; Loudig O; Goldberg MF; Macian F; Arnett HA; Prieto AL; Tsiperson V; Shafit-Zagardo B
J Neuroinflammation; 2011 May; 8():49. PubMed ID: 21569627
[TBL] [Abstract][Full Text] [Related]
12. Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.
Lew ED; Oh J; Burrola PG; Lax I; Zagórska A; Través PG; Schlessinger J; Lemke G
Elife; 2014 Sep; 3():. PubMed ID: 25265470
[TBL] [Abstract][Full Text] [Related]
13. Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies.
Schoumacher M; Burbridge M
Curr Oncol Rep; 2017 Mar; 19(3):19. PubMed ID: 28251492
[TBL] [Abstract][Full Text] [Related]
14. Receptor tyrosine kinases, TYRO3, AXL, and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation.
Tsou WI; Nguyen KQ; Calarese DA; Garforth SJ; Antes AL; Smirnov SV; Almo SC; Birge RB; Kotenko SV
J Biol Chem; 2014 Sep; 289(37):25750-63. PubMed ID: 25074926
[TBL] [Abstract][Full Text] [Related]
15. The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cells.
Park HJ; Baen JY; Lee YJ; Choi YH; Kang JL
Mol Biol Cell; 2012 Aug; 23(16):3254-65. PubMed ID: 22740630
[TBL] [Abstract][Full Text] [Related]
16. Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE.
Orme JJ; Du Y; Vanarsa K; Mayeux J; Li L; Mutwally A; Arriens C; Min S; Hutcheson J; Davis LS; Chong BF; Satterthwaite AB; Wu T; Mohan C
Clin Immunol; 2016 Aug; 169():58-68. PubMed ID: 27237127
[TBL] [Abstract][Full Text] [Related]
17. Complement protein C1q and adiponectin stimulate Mer tyrosine kinase-dependent engulfment of apoptotic cells through a shared pathway.
Galvan MD; Hulsebus H; Heitker T; Zeng E; Bohlson SS
J Innate Immun; 2014; 6(6):780-92. PubMed ID: 24942043
[TBL] [Abstract][Full Text] [Related]
18. Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer.
Linger RM; Cohen RA; Cummings CT; Sather S; Migdall-Wilson J; Middleton DH; Lu X; Barón AE; Franklin WA; Merrick DT; Jedlicka P; DeRyckere D; Heasley LE; Graham DK
Oncogene; 2013 Jul; 32(29):3420-31. PubMed ID: 22890323
[TBL] [Abstract][Full Text] [Related]
19. Axl and Mer Receptor Tyrosine Kinases: Distinct and Nonoverlapping Roles in Inflammation and Cancer?
Dransfield I; Farnworth S
Adv Exp Med Biol; 2016; 930():113-32. PubMed ID: 27558819
[TBL] [Abstract][Full Text] [Related]
20. Identification of Axl as a downstream effector of TGF-β1 during Langerhans cell differentiation and epidermal homeostasis.
Bauer T; Zagórska A; Jurkin J; Yasmin N; Köffel R; Richter S; Gesslbauer B; Lemke G; Strobl H
J Exp Med; 2012 Oct; 209(11):2033-47. PubMed ID: 23071254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
